Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Background: Severe thrombocytopenia is a common complication of extracorporeal membrane oxygenation (ECMO). Oseltamivir can be used to treat infection-associated thrombocytopenia. Objective: To evaluate the effect of oseltamivir on attenuating severe thrombocytopenia during ECMO. Methods: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Wang, Lin, Zhang, Jianning, Han, Hui, Liu, Han, Li, Chaoyang, Guo, Haipeng, Chen, Yuguo, Chen, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349981/
https://www.ncbi.nlm.nih.gov/pubmed/34381822
http://dx.doi.org/10.3389/fcvm.2021.645867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349981/
https://www.ncbi.nlm.nih.gov/pubmed/34381822
http://dx.doi.org/10.3389/fcvm.2021.645867

Ejemplares similares